People | September 06, 2024
Amcor appoints Peter Konieczny as CEO
Konieczny has served as Interim CEO since April 2024
Konieczny has served as Interim CEO since April 2024
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug
Phase 3 clinical trial designed to evaluate the safety and efficacy of tivozanib in combination with nivolumab
Effective, holistic, science-backed targeted solutions for symptomatic treatment
TTP Group is a leading engineering firm specializing in biotech and pharmaceutical industry
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
Innovative product offerings to capitalise on emerging opportunities within and beyond the sexual wellness market
eGenesis is pioneering a genome engineering-based approach in the development of safe and effective transplantable organs to end the global organ shortage
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG)
Subscribe To Our Newsletter & Stay Updated
